Infectious Disease

Both acute and chronic infection can increase the risk of cognitive decline and dementia in older adults.

In a recent trial, investigators found increased rates of screening when human papillomavirus (HPV) self-sampling kits were mailed to participants, and that this process costs less than usual care.

The drug, branded as Rezzayo, is the first FDA-approved invasive candidiasis treatment in over a decade.

Investigators found a robust antigen-specific antibody response against HIV and Zika virus between mothers and newborns in a model using rabbits.

According to a study, patients are frequently prescribed broad-spectrum antibiotics instead of narrowly tailored antibiotics, which would be more optimized to treat them.

England met the new target of the World Health Organization by eliminating the transmission of hepatitis B from mother to child.

To sufficiently address HIV, stakeholders across the health care spectrum must come together.

The FDA has approved another Tdap vaccine option for use during pregnancy to prevent pertussis, otherwise known as whooping cough.

Previously hepatitis B vaccines have offered lower levels of protection for people living with HIV. New research indicates that a 3-dose series could offer much better protection.

The updates include new recommendations for COVID-19 and pneumococcal vaccines.

Childhood vaccinations took a downturn during the pandemic. Now is the time to get them done and pharmacists can help.

In the 3 cases documented by researchers, hepatitis B surface antigen (HBsAG) levels were reduced by more than 50% after Japan began its COVID-19 vaccination program.

A trio of leading hepatitis researchers survey the treatments in development for chronic hepatitis B. They end on a high note: That for the first time in 20 years, a cure is in sight.

Earlier results suggesting that fluvoxamine might be an effective treatment were from trials conducted earlier in the pandemic when vaccines weren’t available and other variants were circulating.

Results of multiple studies were presented at IDWeek 2022.

After multiple approvals and emergency use authorizations, It’s time to take stock of the state of pediatric COVID-19 vaccines.

Investigators reviewed data from 19 studies and 11 consecutive flu seasons.

Antibiotics are often administered to pediatric patients at end of life, even in cases without infection.

Although few cultures showed bacterial coinfections, many children were given antibiotics.

Adult vaccine uptake lags and understanding the reasons could be important.

The US was the first country to begin universal vaccination of children against varicella.

As vaccine hesitancy grows, fewer children are receiving routine childhood vaccines.

Additional research is needed to fully understand the scope of Long COVID.

Moderna’s bivalent mRNA COVID-19 booster reached prespecified superiority and noninferiority criteria against multiple strains of SARS-CoV-2.

The Omicron variant radically changed reinfection rates.

Determining the characteristics that impact antibiotic prescribing behavior is important for addressing health inequity.

A selection of the latest COVID-19 vaccine research out of IDWeek 2022.

What does the uptake look like for one of the most common vaccines given during pregnancy—and what does this mean for the future?